Lab901 launches next-generation RNA quality control for DNA microarray and qRT-PCR

At the Advances in Microarray Technology (AMT) congress in Stockholm, Lab901 unveiled its new ScreenTape R6K product for rapid RNA sample Quality Control (RNA QC). Generating results in as little as 1 minute per sample, ScreenTape R6K extends the use of Lab901’s existing bench-top TapeStation® instrument, which has already started to make a global impact in the PCR diagnostics and protein electrophoresis markets.

ScreenTape R6K is a next-generation platform for RNA QC which automatically delivers an objective quality metric for total RNA - the ScreenTape Degradation Value - prior to expensive and time-consuming experiments such as DNA microarray and qRT-PCR. Lab901’s ScreenTape platform eliminates steps such as gel reagent prep, chip priming and chip-vortexing. Cross priming and sample carry-over problems are eliminated as ScreenTape R6K uses an individual micro-gel for each sample analysis.

Unlike the leading chip-based systems, Lab901’s ScreenTape device can be used more than once. Customers are able to run as little as 1 sample, reserving the rest of the available channels for future experiments. As a result, customers are no longer required to batch samples together or throw away unused portions of the consumable, which improves the RNA QC workflow and saves money.

‘We are very pleased with the response from customers who have evaluated ScreenTape R6K’ commented Lab901’s sales & marketing director Richard Rowling. ‘ScreenTape’s convenience and speed for RNA QC brings tremendous value to customers looking to streamline their RNA QC workflows and wanting to reduce the opportunity for error’ he added.